デフォルト表紙
市場調査レポート
商品コード
1475913

デジタル呼吸器市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、予測、2024年～2032年

Digital Respiratory Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 300 Pages
納期
2～5営業日
カスタマイズ可能
デジタル呼吸器市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、予測、2024年～2032年
出版日: 2024年05月02日
発行: Persistence Market Research
ページ情報: 英文 300 Pages
納期: 2～5営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

当レポートでは、デジタル呼吸器市場の2024年から2032年にかけての市場力学、成長要因、課題、新興動向を詳細に分析しています。デジタル呼吸器市場の現状と将来展望に関する洞察を提供します。

世界のデジタル呼吸器市場は、2024年の671億9,000万米ドルから2032年には4,000億米ドルまで、CAGR25％で成長すると予測されます。

主な洞察

  • 推定市場規模（2024年）：671億9,000万米ドル
  • 予測市場規模（2032年）4,000億米ドル
  • 世界市場成長率（CAGR 2024年～2032年）：25%

デジタル呼吸器市場 - レポート範囲：

デジタル呼吸器には、喘息、慢性閉塞性肺疾患（COPD）、睡眠時無呼吸症候群などの呼吸器疾患の管理および治療に使用される、さまざまな技術対応ソリューションが含まれます。本レポートでは、センサー技術の進歩、遠隔医療、遠隔患者モニタリングなど、デジタル呼吸器の採用が増加している主な要因について概説しています。

市場促進要因：

市場成長の原動力にはいくつかの要因が挙げられます。まず、喘息、COPD、閉塞性睡眠時無呼吸症候群を含む呼吸器疾患の世界の有病率の上昇が、これらの疾患の早期発見、モニタリング、管理のためのデジタル呼吸器の需要を促進しています。さらに、ウェアラブルセンサー、モバイルアプリ、コネクテッドデバイスなどのデジタルヘルスソリューションの技術的進歩により、肺機能、酸素飽和度、呼吸数などの呼吸器パラメータのリアルタイムモニタリングが可能になり、患者や医療提供者は、個別化された治療戦略やタイムリーな介入のための実用的な洞察を得ることができます。さらに、呼吸器疾患管理における予防医療、患者関与、自己管理の重視の高まりは、デジタル呼吸器の採用を促進し、特にサービスが行き届いていない遠隔地のヘルスケア環境において、遠隔モニタリング、遠隔診察、仮想ケア提供モデルを容易にします。

市場抑制要因：

前向きな見通しにもかかわらず、デジタル呼吸器市場は特定の課題に直面しています。データプライバシーに関する懸念、相互運用性の問題、規制上の障壁などの要因が、デジタル呼吸器の普及と既存のヘルスケアエコシステムへの統合を阻害し、その有用性と拡張性を制限する可能性があります。さらに、ヘルスケアへのアクセス、デジタルリテラシー、社会経済的地位の格差は、呼吸器疾患管理と増悪予防における不平等を悪化させ、社会から疎外された人々へのデジタル呼吸器の市場浸透と採用率を妨げる可能性があります。さらに、デジタルヘルス技術に対する償還制限、ヘルスケア償還政策、保険適用制限が、デジタル呼吸器の市場ダイナミクス、投資決定、商業化戦略に影響を与え、市場の成長と持続可能性に課題をもたらす可能性があります。

市場機会：

デジタル呼吸器市場には、技術革新と市場拡大の大きな機会があります。メーカーや開発者は、ワイヤレス接続、クラウドベースのデータ分析、予測分析や個別化されたケア推奨のための人工知能アルゴリズムなどの強化された機能を備えた、ユーザーフレンドリーでコスト効率の高いデジタル呼吸器の開発に注力することができます。例えば、センサーとブルートゥース接続を備えたスマート吸入器は、服薬アドヒアランス、吸入技術、環境トリガーのリアルタイム追跡を可能にし、呼吸器疾患患者の治療アドヒアランス、吸入技術、喘息コントロールを強化します。さらに、ヘルスケアプロバイダー、支払者、技術パートナーとの戦略的提携、パートナーシップ、パイロットプロジェクトは、臨床診療、在宅ヘルスケア、遠隔医療アプリケーションにおけるデジタル呼吸器の市場参入、検証、採用を促進します。さらに、研究開発、臨床検証、規制遵守への投資により、企業は未充足のニーズに対応し、臨床効果を実証し、デジタル呼吸器の規制当局の承認を得ることができ、世界のデジタル呼吸器市場における差別化と競争優位性を促進することができます。

レポートで扱う主な質問

  • 2024年～2032年のデジタル呼吸器市場の予想CAGRは？
  • デジタル呼吸器市場の成長を促進する主な要因は何か？
  • 最大の市場シェアを占めるデジタル呼吸器のタイプは？
  • デジタル呼吸器の世界市場における主要企業は？
  • デジタル呼吸器市場で競合を維持するために主要企業はどのような戦略を採用しているか？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 機会マップ分析
  • 投資実現可能性マトリックス
  • PESTLEとポーター分析
  • 規制状況
  • 地域別の親市場見通し

第4章 世界のデジタル呼吸器市場分析

  • 過去の市場規模分析（2019年～2023年）
  • 現在および将来の市場規模予測（2024年～2032年）
    • 前年比成長動向分析
    • 絶対額の機会分析

第5章 世界のデジタル呼吸器市場分析：製品別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析（2019年～2023年）：製品別
  • 現在および将来の市場規模分析と予測（2024年～2032年）：製品別
    • スマート吸入器とネブライザー
    • センサーとアプリ
  • 前年比成長動向分析（2019年～2023年）：製品別
  • 絶対額の機会分析（2024年～2032年）：製品別

第6章 世界のデジタル呼吸器市場分析：適応症別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析（2019年～2023年）：適応症別
  • 現在および将来の市場規模分析と予測（2024年～2032年）：適応症別
    • 喘息
    • 慢性閉塞性肺疾患
    • その他の病気
  • 前年比成長動向分析（2019年～2023年）：適応症別
  • 絶対額の機会分析（2024年～2032年）：適応症別

第7章 世界のデジタル呼吸器市場分析：最終用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析（2019年～2023年）：最終用途別
  • 現在および将来の市場規模分析と予測（2024年～2032年）：最終用途別
    • 病院
    • 在宅ケア
    • その他
  • 前年比成長動向分析（2019年～2023年）：最終用途別
  • 絶対額の機会分析（2024年～2032年）：最終用途別

第8章 世界のデジタル呼吸器市場分析：流通チャネル別

  • イントロダクション/主な調査結果
  • 過去の市場規模分析（2019年～2023年）：流通チャネル別
  • 現在および将来の市場規模分析と予測（2024年～2032年）：流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 前年比成長動向分析（2019年～2023年）：流通チャネル別
  • 絶対額の機会分析（2024年～2032年）：流通チャネル別

第9章 世界のデジタル呼吸器市場分析：地域別

  • イントロダクション
  • 過去の市場規模分析（2019年～2023年）：地域別
  • 現在および将来の市場規模分析と予測（2024年～2032年）：地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別の市場魅力度分析

第10章 北米のデジタル呼吸器市場分析：国別

第11章 ラテンアメリカのデジタル呼吸器市場分析：国別

第12章 欧州のデジタル呼吸器市場分析：国別

第13章 南アジアのデジタル呼吸器市場分析：国別

第14章 東アジアのデジタル呼吸器市場分析：国別

第15章 オセアニアのデジタル呼吸器市場分析：国別

第16章 中東・アフリカのデジタル呼吸器市場分析：国別

第17章 主要国のデジタル呼吸器市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • インド
  • マレーシア
  • シンガポール
  • タイ
  • 中国
  • 日本
  • 韓国
  • オーストラリア
  • ニュージーランド
  • GCC諸国
  • 南アフリカ
  • イスラエル

第18章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第19章 競合分析

  • 競合の競合
    • COHERO Health Inc.
    • Cognita Labs
    • Adherium Limited
    • Amiko Digital Health Limited
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M Health Care Limited
    • AireHealth, Inc.

第20章 前提と頭字語

第21章 調査手法

目次
Product Code: PMRREP33183

The Digital Respiratory Devices Market report by Persistence Market Research provides an in-depth analysis of market dynamics, growth factors, challenges, and emerging trends from 2024 to 2032. It offers insights into the current state and future outlook of the Digital Respiratory Devices Market.

The global digital respiratory devices market is projected to grow at a compound annual growth rate (CAGR) of 25% from USD 67.19 billion in 2024 to USD 400 billion by 2032.

Key Insights:

  • Estimated Market Size (2024): USD 67.19 Billion
  • Projected Market Size (2032): USD 400 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 25%

Digital Respiratory Devices Market - Report Scope:

Digital respiratory devices encompass a range of technology-enabled solutions used in the management and treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. The report outlines key drivers behind the increasing adoption of digital respiratory devices, including advancements in sensor technology, telemedicine, and remote patient monitoring.

Market Growth Drivers:

The market's growth is driven by several factors. Firstly, the rising prevalence of respiratory diseases, including asthma, COPD, and obstructive sleep apnea, globally, fuels demand for digital respiratory devices for early detection, monitoring, and management of these conditions. Additionally, technological advancements in digital health solutions, including wearable sensors, mobile apps, and connected devices, enable real-time monitoring of respiratory parameters such as lung function, oxygen saturation, and respiratory rate, empowering patients and healthcare providers with actionable insights for personalized treatment strategies and timely interventions. Moreover, the growing emphasis on preventive care, patient engagement, and self-management in respiratory disease management drives adoption of digital respiratory devices, facilitating remote monitoring, teleconsultations, and virtual care delivery models, particularly in underserved and remote healthcare settings.

Market Restraints:

Despite the positive outlook, the Digital Respiratory Devices Market faces certain challenges. Factors such as data privacy concerns, interoperability issues, and regulatory barriers may impede widespread adoption and integration of digital respiratory devices into existing healthcare ecosystems, limiting their utility and scalability. Moreover, disparities in healthcare access, digital literacy, and socioeconomic status may exacerbate inequalities in respiratory disease management and exacerbation prevention, hindering market penetration and adoption rates of digital respiratory devices among marginalized populations. Additionally, reimbursement limitations, healthcare reimbursement policies, and coverage restrictions for digital health technologies may impact market dynamics, investment decisions, and commercialization strategies for digital respiratory devices, posing challenges to market growth and sustainability.

Market Opportunities:

The Digital Respiratory Devices Market offers significant opportunities for innovation and market expansion. Manufacturers and developers can focus on developing user-friendly, cost-effective digital respiratory devices with enhanced features such as wireless connectivity, cloud-based data analytics, and artificial intelligence algorithms for predictive analytics and personalized care recommendations. For instance, smart inhalers equipped with sensors and Bluetooth connectivity enable real-time tracking of medication adherence, inhaler technique, and environmental triggers, enhancing treatment adherence, inhaler technique, and asthma control in patients with respiratory conditions. Moreover, strategic collaborations, partnerships, and pilot projects with healthcare providers, payers, and technology partners facilitate market access, validation, and adoption of digital respiratory devices in clinical practice, home healthcare, and telemedicine applications. Furthermore, investments in research and development, clinical validation, and regulatory compliance enable companies to address unmet needs, demonstrate clinical efficacy, and gain regulatory approvals for digital respiratory devices, driving market differentiation and competitive advantage in the global digital respiratory devices market.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the Digital Respiratory Devices Market from 2024 to 2032?
  • What are the Key Factors Driving the Growth of the Digital Respiratory Devices Market?
  • Which Type of Digital Respiratory Device Holds the Largest Market Share?
  • Who are the Key Players in the Global Digital Respiratory Devices Market?
  • What Strategies are Adopted by Leading Companies to Stay Competitive in the Digital Respiratory Devices Market?

Competitive Landscape and Business Strategies:

Key players in the Digital Respiratory Devices Market include Propeller Health (a ResMed Company), Adherium Limited, Teva Pharmaceuticals Industries Ltd., Cohero Health, and NuvoAir, among others. These companies focus on product innovation, strategic partnerships, and market expansion to maintain a competitive edge in the market. For instance, Propeller Health offers a range of digital health solutions for asthma and COPD management, including sensor-enabled inhaler devices, mobile apps, and population health analytics platforms, while Adherium Limited specializes in smart medication adherence solutions for respiratory diseases. Market players also invest in clinical trials, real-world evidence generation, and regulatory approvals to demonstrate clinical efficacy, safety, and value proposition of digital respiratory devices, fostering adoption by healthcare providers, payers, and patients in the global market.

Key Companies Profiled:

  • COHERO Health Inc.
  • Cognita Labs
  • Adherium limited
  • Amiko Digital Health Limited
  • Teva pharmaceuticals industries Ltd.
  • Propeller Health
  • Novartis AG
  • Pneuma Respiratory Inc.
  • 3m Health Care Limited
  • AireHealth, Inc.

Digital Respiratory Devices Market Segmentation:

By Product

  • Smart Inhalers & Nebulizers
  • Sensors & Apps

By Indication

  • Asthma
  • COPD
  • Other Diseases

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End Use

  • Hospitals
  • Homecare Settings
  • Other settings

By Region

  • North America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Product

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
    • 5.3.1. Smart inhalers & Nebulizers
    • 5.3.2. Sensors & Apps
  • 5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Indication

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2024-2032
    • 6.3.1. Asthma
    • 6.3.2. COPD
    • 6.3.3. Other Diseases
  • 6.4. Y-o-Y Growth Trend Analysis By Indication, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Indication, 2024-2032

7. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By End-Use

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By End-Use , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-Use , 2024-2032
    • 7.3.1. Hospitals
    • 7.3.2. Homecare Settings
    • 7.3.3. Other settings
  • 7.4. Y-o-Y Growth Trend Analysis By End-Use , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By End-Use , 2024-2032

8. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Distribution Channel

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2019-2023
  • 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2032
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019-2023
  • 8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024-2032

9. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. South Asia
    • 9.3.5. East Asia
    • 9.3.6. Oceania
    • 9.3.7. MEA
  • 9.4. Market Attractiveness Analysis By Region

10. North America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. U.S.
      • 10.2.1.2. Canada
    • 10.2.2. By Product
    • 10.2.3. By Indication
    • 10.2.4. By End-Use
    • 10.2.5. By Distribution Channel
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Indication
    • 10.3.4. By End-Use
    • 10.3.5. By Distribution Channel
  • 10.4. Key Takeaways

11. Latin America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Brazil
      • 11.2.1.2. Mexico
      • 11.2.1.3. Rest of Latin America
    • 11.2.2. By Product
    • 11.2.3. By Indication
    • 11.2.4. By End-Use
    • 11.2.5. By Distribution Channel
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product
    • 11.3.3. By Indication
    • 11.3.4. By End-Use
    • 11.3.5. By Distribution Channel
  • 11.4. Key Takeaways

12. Europe Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. Germany
      • 12.2.1.2. U.K.
      • 12.2.1.3. France
      • 12.2.1.4. Spain
      • 12.2.1.5. Italy
      • 12.2.1.6. Rest of Europe
    • 12.2.2. By Product
    • 12.2.3. By Indication
    • 12.2.4. By End-Use
    • 12.2.5. By Distribution Channel
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product
    • 12.3.3. By Indication
    • 12.3.4. By End-Use
    • 12.3.5. By Distribution Channel
  • 12.4. Key Takeaways

13. South Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Malaysia
      • 13.2.1.3. Singapore
      • 13.2.1.4. Thailand
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Product
    • 13.2.3. By Indication
    • 13.2.4. By End-Use
    • 13.2.5. By Distribution Channel
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End-Use
    • 13.3.5. By Distribution Channel
  • 13.4. Key Takeaways

14. East Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. China
      • 14.2.1.2. Japan
      • 14.2.1.3. South Korea
    • 14.2.2. By Product
    • 14.2.3. By Indication
    • 14.2.4. By End-Use
    • 14.2.5. By Distribution Channel
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End-Use
    • 14.3.5. By Distribution Channel
  • 14.4. Key Takeaways

15. Oceania Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. Australia
      • 15.2.1.2. New Zealand
    • 15.2.2. By Product
    • 15.2.3. By Indication
    • 15.2.4. By End-Use
    • 15.2.5. By Distribution Channel
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End-Use
    • 15.3.5. By Distribution Channel
  • 15.4. Key Takeaways

16. MEA Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 16.2.1. By Country
      • 16.2.1.1. GCC Countries
      • 16.2.1.2. South Africa
      • 16.2.1.3. Israel
      • 16.2.1.4. Rest of MEA
    • 16.2.2. By Product
    • 16.2.3. By Indication
    • 16.2.4. By End-Use
    • 16.2.5. By Distribution Channel
  • 16.3. Market Attractiveness Analysis
    • 16.3.1. By Country
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End-Use
    • 16.3.5. By Distribution Channel
  • 16.4. Key Takeaways

17. Key Countries Digital Respiratory Devices Market Analysis

  • 17.1. U.S.
    • 17.1.1. Pricing Analysis
    • 17.1.2. Market Share Analysis, 2023
      • 17.1.2.1. By Product
      • 17.1.2.2. By Indication
      • 17.1.2.3. By End-Use
      • 17.1.2.4. By Distribution Channel
  • 17.2. Canada
    • 17.2.1. Pricing Analysis
    • 17.2.2. Market Share Analysis, 2023
      • 17.2.2.1. By Product
      • 17.2.2.2. By Indication
      • 17.2.2.3. By End-Use
      • 17.2.2.4. By Distribution Channel
  • 17.3. Brazil
    • 17.3.1. Pricing Analysis
    • 17.3.2. Market Share Analysis, 2023
      • 17.3.2.1. By Product
      • 17.3.2.2. By Indication
      • 17.3.2.3. By End-Use
      • 17.3.2.4. By Distribution Channel
  • 17.4. Mexico
    • 17.4.1. Pricing Analysis
    • 17.4.2. Market Share Analysis, 2023
      • 17.4.2.1. By Product
      • 17.4.2.2. By Indication
      • 17.4.2.3. By End-Use
      • 17.4.2.4. By Distribution Channel
  • 17.5. Germany
    • 17.5.1. Pricing Analysis
    • 17.5.2. Market Share Analysis, 2023
      • 17.5.2.1. By Product
      • 17.5.2.2. By Indication
      • 17.5.2.3. By End-Use
      • 17.5.2.4. By Distribution Channel
  • 17.6. U.K.
    • 17.6.1. Pricing Analysis
    • 17.6.2. Market Share Analysis, 2023
      • 17.6.2.1. By Product
      • 17.6.2.2. By Indication
      • 17.6.2.3. By End-Use
      • 17.6.2.4. By Distribution Channel
  • 17.7. France
    • 17.7.1. Pricing Analysis
    • 17.7.2. Market Share Analysis, 2023
      • 17.7.2.1. By Product
      • 17.7.2.2. By Indication
      • 17.7.2.3. By End-Use
      • 17.7.2.4. By Distribution Channel
  • 17.8. Spain
    • 17.8.1. Pricing Analysis
    • 17.8.2. Market Share Analysis, 2023
      • 17.8.2.1. By Product
      • 17.8.2.2. By Indication
      • 17.8.2.3. By End-Use
      • 17.8.2.4. By Distribution Channel
  • 17.9. Italy
    • 17.9.1. Pricing Analysis
    • 17.9.2. Market Share Analysis, 2023
      • 17.9.2.1. By Product
      • 17.9.2.2. By Indication
      • 17.9.2.3. By End-Use
      • 17.9.2.4. By Distribution Channel
  • 17.10. India
    • 17.10.1. Pricing Analysis
    • 17.10.2. Market Share Analysis, 2023
      • 17.10.2.1. By Product
      • 17.10.2.2. By Indication
      • 17.10.2.3. By End-Use
      • 17.10.2.4. By Distribution Channel
  • 17.11. Malaysia
    • 17.11.1. Pricing Analysis
    • 17.11.2. Market Share Analysis, 2023
      • 17.11.2.1. By Product
      • 17.11.2.2. By Indication
      • 17.11.2.3. By End-Use
      • 17.11.2.4. By Distribution Channel
  • 17.12. Singapore
    • 17.12.1. Pricing Analysis
    • 17.12.2. Market Share Analysis, 2023
      • 17.12.2.1. By Product
      • 17.12.2.2. By Indication
      • 17.12.2.3. By End-Use
      • 17.12.2.4. By Distribution Channel
  • 17.13. Thailand
    • 17.13.1. Pricing Analysis
    • 17.13.2. Market Share Analysis, 2023
      • 17.13.2.1. By Product
      • 17.13.2.2. By Indication
      • 17.13.2.3. By End-Use
      • 17.13.2.4. By Distribution Channel
  • 17.14. China
    • 17.14.1. Pricing Analysis
    • 17.14.2. Market Share Analysis, 2023
      • 17.14.2.1. By Product
      • 17.14.2.2. By Indication
      • 17.14.2.3. By End-Use
      • 17.14.2.4. By Distribution Channel
  • 17.15. Japan
    • 17.15.1. Pricing Analysis
    • 17.15.2. Market Share Analysis, 2023
      • 17.15.2.1. By Product
      • 17.15.2.2. By Indication
      • 17.15.2.3. By End-Use
      • 17.15.2.4. By Distribution Channel
  • 17.16. South Korea
    • 17.16.1. Pricing Analysis
    • 17.16.2. Market Share Analysis, 2023
      • 17.16.2.1. By Product
      • 17.16.2.2. By Indication
      • 17.16.2.3. By End-Use
      • 17.16.2.4. By Distribution Channel
  • 17.17. Australia
    • 17.17.1. Pricing Analysis
    • 17.17.2. Market Share Analysis, 2023
      • 17.17.2.1. By Product
      • 17.17.2.2. By Indication
      • 17.17.2.3. By End-Use
      • 17.17.2.4. By Distribution Channel
  • 17.18. New Zealand
    • 17.18.1. Pricing Analysis
    • 17.18.2. Market Share Analysis, 2023
      • 17.18.2.1. By Product
      • 17.18.2.2. By Indication
      • 17.18.2.3. By End-Use
      • 17.18.2.4. By Distribution Channel
  • 17.19. GCC Countries
    • 17.19.1. Pricing Analysis
    • 17.19.2. Market Share Analysis, 2023
      • 17.19.2.1. By Product
      • 17.19.2.2. By Indication
      • 17.19.2.3. By End-Use
      • 17.19.2.4. By Distribution Channel
  • 17.20. South Africa
    • 17.20.1. Pricing Analysis
    • 17.20.2. Market Share Analysis, 2023
      • 17.20.2.1. By Product
      • 17.20.2.2. By Indication
      • 17.20.2.3. By End-Use
      • 17.20.2.4. By Distribution Channel
  • 17.21. Israel
    • 17.21.1. Pricing Analysis
    • 17.21.2. Market Share Analysis, 2023
      • 17.21.2.1. By Product
      • 17.21.2.2. By Indication
      • 17.21.2.3. By End-Use
      • 17.21.2.4. By Distribution Channel

18. Market Structure Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Market Share Analysis of Top Players
    • 18.3.1. By Regional
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End-Use
    • 18.3.5. By Distribution Channel

19. Competition Analysis

  • 19.1. Competition Deep Dive
    • 19.1.1. COHERO Health Inc.
      • 19.1.1.1. Overview
      • 19.1.1.2. Product Portfolio
      • 19.1.1.3. Profitability by Market Segments
      • 19.1.1.4. Sales Footprint
      • 19.1.1.5. Strategy Overview
        • 19.1.1.5.1. Marketing Strategy
    • 19.1.2. Cognita Labs
      • 19.1.2.1. Overview
      • 19.1.2.2. Product Portfolio
      • 19.1.2.3. Profitability by Market Segments
      • 19.1.2.4. Sales Footprint
      • 19.1.2.5. Strategy Overview
        • 19.1.2.5.1. Marketing Strategy
    • 19.1.3. Adherium Limited
      • 19.1.3.1. Overview
      • 19.1.3.2. Product Portfolio
      • 19.1.3.3. Profitability by Market Segments
      • 19.1.3.4. Sales Footprint
      • 19.1.3.5. Strategy Overview
        • 19.1.3.5.1. Marketing Strategy
    • 19.1.4. Amiko Digital Health Limited
      • 19.1.4.1. Overview
      • 19.1.4.2. Product Portfolio
      • 19.1.4.3. Profitability by Market Segments
      • 19.1.4.4. Sales Footprint
      • 19.1.4.5. Strategy Overview
        • 19.1.4.5.1. Marketing Strategy
    • 19.1.5. Teva Pharmaceuticals Industries Ltd.
      • 19.1.5.1. Overview
      • 19.1.5.2. Product Portfolio
      • 19.1.5.3. Profitability by Market Segments
      • 19.1.5.4. Sales Footprint
      • 19.1.5.5. Strategy Overview
        • 19.1.5.5.1. Marketing Strategy
    • 19.1.6. Propeller Health
      • 19.1.6.1. Overview
      • 19.1.6.2. Product Portfolio
      • 19.1.6.3. Profitability by Market Segments
      • 19.1.6.4. Sales Footprint
      • 19.1.6.5. Strategy Overview
        • 19.1.6.5.1. Marketing Strategy
    • 19.1.7. Novartis AG
      • 19.1.7.1. Overview
      • 19.1.7.2. Product Portfolio
      • 19.1.7.3. Profitability by Market Segments
      • 19.1.7.4. Sales Footprint
      • 19.1.7.5. Strategy Overview
        • 19.1.7.5.1. Marketing Strategy
    • 19.1.8. Pneuma Respiratory Inc.
      • 19.1.8.1. Overview
      • 19.1.8.2. Product Portfolio
      • 19.1.8.3. Profitability by Market Segments
      • 19.1.8.4. Sales Footprint
      • 19.1.8.5. Strategy Overview
        • 19.1.8.5.1. Marketing Strategy
    • 19.1.9. 3M Health Care Limited
      • 19.1.9.1. Overview
      • 19.1.9.2. Product Portfolio
      • 19.1.9.3. Profitability by Market Segments
      • 19.1.9.4. Sales Footprint
      • 19.1.9.5. Strategy Overview
        • 19.1.9.5.1. Marketing Strategy
    • 19.1.10. AireHealth, Inc.
      • 19.1.10.1. Overview
      • 19.1.10.2. Product Portfolio
      • 19.1.10.3. Profitability by Market Segments
      • 19.1.10.4. Sales Footprint
      • 19.1.10.5. Strategy Overview
        • 19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology